Provided By PR Newswire
Last update: Dec 4, 2024
SAN JOSE, Calif, Dec. 4, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, announced today that it will be participating in the iAccess Alpha Virtual Best Ideas Winter Conference 2024 being held on December 10th and 11th, 2024.
Read more at prnewswire.comNASDAQ:ANIX (6/24/2025, 9:50:38 AM)
3.465
-0.03 (-0.72%)
Find more stocks in the Stock Screener